Kumar S, Wang M, Kim AS, Center JR, et al. Denosumab discontinuation in the clinic: implications of rebound bone turnover and emerging strategies to prevent bone loss and fractures. J Bone Miner Res 2025 Mar 9:zjaf037. doi: 10.1093.
PMID: 40057981